Immunogenicity and tolerability of a SARS-CoV-2 TNX-1800, a live recombinant poxvirus vaccine candidate, in Syrian Hamsters and New Zealand White Rabbits.
M. Awasthi, A. Macaluso, S. J. Goebel, E. Luea, R. S. Noyce, F. Nasar, B. Daugherty, S. Bavari, S. Lederman
This study evaluates the immunogenicity and tolerability of the SARS-CoV-2 vaccine TNX-1800 in hamsters and rabbits, finding it well-tolerated with undetectable viral load after 28 days.
bioRxiv · Sep 6, 2023Immunology